Tango Therapeutics (TNGX) Research & Development: 2020-2025
Historic Research & Development for Tango Therapeutics (TNGX) over the last 5 years, with Sep 2025 value amounting to $30.8 million.
- Tango Therapeutics' Research & Development fell 7.36% to $30.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $134.0 million, marking a year-over-year decrease of 5.18%. This contributed to the annual value of $143.9 million for FY2024, which is 24.93% up from last year.
- According to the latest figures from Q3 2025, Tango Therapeutics' Research & Development is $30.8 million, which was down 6.07% from $32.8 million recorded in Q2 2025.
- Over the past 5 years, Tango Therapeutics' Research & Development peaked at $38.7 million during Q2 2024, and registered a low of $15.0 million during Q1 2021.
- Moreover, its 3-year median value for Research & Development was $32.8 million (2025), whereas its average is $32.7 million.
- As far as peak fluctuations go, Tango Therapeutics' Research & Development soared by 68.94% in 2021, and later declined by 15.13% in 2025.
- Quarterly analysis of 5 years shows Tango Therapeutics' Research & Development stood at $21.6 million in 2021, then surged by 34.47% to $29.1 million in 2022, then rose by 7.73% to $31.3 million in 2023, then grew by 8.29% to $33.9 million in 2024, then declined by 7.36% to $30.8 million in 2025.
- Its Research & Development was $30.8 million in Q3 2025, compared to $32.8 million in Q2 2025 and $36.4 million in Q1 2025.